American Society of Clinical Oncology

SHERPA: White

People

  1. Slovin
    Slovin
  2. Scher
    Scher
  3. Morris
    Morris
  4. Danila
    Danila
  5. Rathkopf
    Rathkopf
  6. Autio
    Autio
  7. Abida
    Abida
  8. Solit
    Solit
  9. Fleisher
    Fleisher
  10. De La Cruz
    De La Cruz

Groups

  1. Department of Medicine (83)
  2. Genitourinary Oncology Service (83)
  3. Hematologic Malignancies, Division of (83)
  4. Solid Tumor Oncology Division (83)
  5. GSK Faculty (34)
  6. Molecular Pharmacology and Chemistry Program Faculty (22)
  7. Radiology, Department of (22)
  8. Sloan Kettering Institute Faculty (22)
  9. Nursing (21)
  10. Human Oncology and Pathogenesis Program (19)
Search Within
  1. "Genitourinary Oncology Service"
  2. "Susan Slovin"
Formats
  1. Meeting Abstract (68)
  2. Journal Article (14)
  3. Editorial (1)
Groups
  1. Department of Medicine (83)
  2. Genitourinary Oncology Service (83)
  3. Hematologic Malignancies, Division of (83)
  4. Solid Tumor Oncology Division (83)
  5. GSK Faculty (34)
  6. Molecular Pharmacology and Chemistry Program Faculty (22)

More Groups

People
  1. Susan Slovin (83)
  2. Howard Scher (63)
  3. Michael Morris (44)
  4. Dana Rathkopf (38)
  5. Daniel Danila (25)
  6. Steven Larson (16)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
  3. 2021 (2)
  4. 2020 (6)
  5. 2019 (6)
  6. 2018 (6)

More Years

Publications
  1. Journal of Clinical Oncology (80)
  2. JCO Precision Oncology (2)
  3. American Society of Clinical Oncology Educational Book (1)

Results (83)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II multicenter trial of abiraterone acetate with or without cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
    Journal Article

    Slovin, S. F.; Knudsen, K.; Halabi, S.; de Leeuw, R.; Shafi, A.; Kang, P.; Wolf, S.; Luo, B.; Gopalan, A.; Curley, T.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • HB-300, a novel arenavirus-based cancer immunotherapy in patients with metastatic castration-resistant prostate cancer
    Meeting Abstract

    Chism, D. D.; Saraiya, B.; Dorff, T. B.; Curti, B. D.; Posadas, E. M.; St. Paul, C.; Mukhopadhyay, S.; Desai, L.; Lauterbach, H.; Nassirpour, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Raising the level of cancer care: Feasibility and reported benefit of a virtual tumor board
    Meeting Abstract

    Chiec, L.; Dempsey, N.; Agarwal, M. S.; Ogden, J. R.; Broughman, J. R.; Mayo, Z.; Shonkwiler, E.; Chaby, M.; Socinski, M. A.; Pegram, M. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Dorff, T. B.; Falchook, G. S.; Wei, X. X.; Gao, X.; McKay, R. R.; Oh, D. Y.; Wibmer, A. G.; Spear, M. A.; McCaigue, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality
    Meeting Abstract

    Keegan, N. M.; Vasselman, S. E.; Barnett, E.; Nweji, B.; Carbone, E.; Blum, A.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • TROP-2 co-expression with androgen receptor splice variants as a new therapeutic target in prostate cancer
    Meeting Abstract

    Stahlfeld, C.; Sperger, J.; Slovin, S. F.; Tagawa, S. T.; Kyriakopoulos, C.; Kohli, M.; Wang, L. G.; Wang, L. W.; Dehm, S.; Lang, J. M.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Interim results of AASUR: A single arm, multi-center phase 2 trial of apalutamide (A) + abiraterone acetate + prednisone (AA plus P) + leuprolide with stereotactic ultra-hypofractionated radiation (UHRT) in very high risk (VHR), node negative (N0) prostate cancer (PCa)
    Meeting Abstract

    McBride, S. M.; Spratt, D. E.; Kollmeier, M.; Abida, W.; Xiao, H.; Slovin, S. F.; Paller, C. J.; Deville, C.; Den, R. B.; Hearn, J. W. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Evaluation of immune-related adverse events (irAE): Utilizing the patient-reported outcomes of the common terminology criteria for adverse events (PRO-CTCAE) in a phase II study of ipilimumab (ipi) in men with castration-sensitive prostate cancer (CSPC)
    Meeting Abstract

    Vargas Pivato de Almeida, D.; Anderson, J.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Dayan, E. S.; Curley, T.; Arauz, G.; Baser, R. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Changes in Ki-67 and cleaved caspase-3 (CC3) with short term androgen deprivation therapy (ADT) prior to prostatectomy as part of a trial in intermediate and high-risk prostate cancer (PC)
    Meeting Abstract

    Vargas Pivato de Almeida, D.; Chen, Y. B.; Autio, K. A.; Carver, B. S.; Slovin, S. F.; Danila, D. C.; Scher, H. I.; Touijer, K. A.; Rathkopf, D. E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Platinum-based chemotherapy in metastatic prostate cancer with DNA repair gene alterations
    Journal Article

    Mota, J. M.; Barnett, E.; Nauseef, J. T.; Nguyen, B.; Stopsack, K. H.; Wibmer, A.; Flynn, J. R.; Heller, G.; Danila, D. C.; Rathkopf, D.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save